Pharmaceutical companies are under fire again for their role in the national opioid abuse epidemic, and this time, it could be criminal. Federal prosecutors have opened a criminal probe to determine if pharmaceutical companies intentionally allowed the flow of opioid drugs, The Wall Street Journal reported.

The “Better and Robust Screening Today Act” would require the Department of Defense to cover digital breast tomosynthesis, the most effective screening tool for diagnosing breast cancer, according to the lawmakers.

CMS issued more details and opened up applications for its upcoming direct contracting models that draw lessons from accountable care organizations and aim to promote shared risk.

A major industry group representing pharmaceutical companies has ceased funding to a nonprofit group that aims to help people addicted to opioids, Politico reported.

Hospitals provided about $12.8 million on average in uncompensated care in 2018, according to a new report from Definitive Healthcare.

AI is expected to have a transformative impact on healthcare, especially radiology. According to a new analysis in the European Journal of Radiology, however, there are significant ethical issues that need to be addressed for any legitimate progress to be made.

Congress is seeking more information from a proposed rule from HHS that would allow third-party vendors to have access to patient data in order for consumers to view and access their own personal health information.

President Trump plans to hold a meeting with officials from the e-cigarette industry and medical field amid an epidemic of vaping-related illnesses and deaths, The Wall Street Journal reported.